FDA Closer to Approving CRISPR Gene Editing Treatment for Sickle Cell Disease

Proposed Gene Therapy Uses CRISPR Technology to Alter Patient's Stem Cells, Showing Promising Results in Trials and Could Offer Lifelong Relief from Debilitating Disease